BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 12523344)

  • 1. Genetic testing for breast and ovarian cancer: implications for life insurance.
    Lemaire J; Subramanian K; Asch DA
    LDI Issue Brief; 2000 Mar; 5(6):1-4. PubMed ID: 12523344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legal rules and industry norms: the impact of laws restricting health insurers' use of genetic information.
    Hall MA
    Jurimetrics; 1999; 40(1):93-122. PubMed ID: 12737178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposal: a position for the insurance industry on genetic testing.
    Lowden JA
    J Insur Med; 1997; 29(4):260-2. PubMed ID: 10184929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human genetics. A rational view of insurance and genetic discrimination.
    Nowlan W
    Science; 2002 Jul; 297(5579):195-6. PubMed ID: 12114609
    [No Abstract]   [Full Text] [Related]  

  • 6. Should insurance pay for preventive services suggested by genetics?
    Lawrence J
    Manag Care; 1997 Jan; 6(1):42-6. PubMed ID: 10164532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finance issue brief: genetic testing.
    Herstek J
    Issue Brief Health Policy Track Serv; 1999 Jun; ():1-10. PubMed ID: 11073390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding prohibitions against genetic discrimination in insurance.
    Abraham KS
    Jurimetrics; 1999; 40():123-8. PubMed ID: 15744896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic testing, adverse selection, and the demand for life insurance.
    Zick CD; Smith KR; Mayer RN; Botkin JR
    Am J Med Genet; 2000 Jul; 93(1):29-39. PubMed ID: 10861679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic information and life insurance: a 'real' risk?
    Joly Y; Knoppers BM; Godard B
    Eur J Hum Genet; 2003 Aug; 11(8):561-4. PubMed ID: 12891375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic testing for breast and ovarian cancer susceptibility: a family experience.
    Van Riper M; McKinnon WC
    J Midwifery Womens Health; 2004; 49(3):210-9. PubMed ID: 15134674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of genetic testing: discrimination in life insurance and future directions.
    Mould A
    J Law Med; 2003 May; 10(4):470-87. PubMed ID: 12852320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary breast and ovarian cancer syndrome: should we test adolescents?
    Seeber B; Driscoll DA
    J Pediatr Adolesc Gynecol; 2004 Jun; 17(3):161-7. PubMed ID: 15125901
    [No Abstract]   [Full Text] [Related]  

  • 14. BRCA1 and BRCA2 cancer risks.
    Antoniou AC; Pharoah PD; Easton DF; Evans DG
    J Clin Oncol; 2006 Jul; 24(20):3312-3; author reply 3313-4. PubMed ID: 16829658
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer.
    Forman AD; Hall MJ
    Breast J; 2009; 15 Suppl 1():S56-62. PubMed ID: 19775331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mother still knows best: cancer-related gene mutations, familial privacy, and a physician's duty to warn.
    Brownrigg A
    Fordham Urban Law J; 1999 Jan; 26(2):247-79. PubMed ID: 16437785
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jul; 53(27):603-6. PubMed ID: 15254451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging the gap between life insurer and consumer in the genetic testing era: the RF proposal.
    Keefer CM
    Indiana Law J; 1999; 74(4):1375-95. PubMed ID: 16211754
    [No Abstract]   [Full Text] [Related]  

  • 19. Insurers keep genetic test options open.
    Brower V
    Nat Biotechnol; 1997 Aug; 15(8):708-9. PubMed ID: 9333518
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic testing for hereditary breast and ovarian cancer: responsibility and choice.
    d'Agincourt-Canning L
    Qual Health Res; 2006 Jan; 16(1):97-118. PubMed ID: 16317179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.